Parexel Drug Trial Had Shortfalls, UK Probe Finds
May 25 (Bloomberg) -- Parexel International Corp., which ran a drug trial in London that left six men with multiple organ failure earlier this year, didn't have a doctor with adequate training screening the patients, the U.K. health regulator said.
Parexel, based in Waltham, Massachusetts, also failed to have a contract in place with the drug's developer, TeGenero AG, the Medicines and Healthcare products Regulatory Agency said today in an e-mailed statement. There was also no formal system to provide 24-hour medical cover, and Parexel didn't complete medical checks of patients, the London-based agency said.
· Read The Full Kidney Failure Article From Bloomberg -->
·
Read All Kidney Failure News Stories -->